Dufour, Jean-Francois

Publishing since 1992 (Senior)

Has published 79 publications in 19 years

Number of publications published per year by Dufour, Jean-Francois. (Source : PubMed)

Distribution of publications types for Dufour, Jean-Francois. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Rauch A, Kutalik Z, Descombes P, Cai T, Di Iulio J, Mueller T, Bochud M, Battegay M, Bernasconi E, Borovicka J, Colombo S, Cerny A, Dufour JF, Furrer H, Günthard HF, Heim M, Hirschel B, Malinverni R, Moradpour D, Müllhaupt B, Witteck A, Beckmann JS, Berg T, Bergmann S, Negro F, Telenti A, Bochud PY. Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study.  Gastroenterology  2010;138;4  
•  Green L, Kahn JE, Dufour JF, Le Scanff J, Charhon A, Broussolle C, Sève P. [Efficiency of imatinib in polyserositis revealing a FIP1L1-PDGFRA-negative hypereosinophilic syndrome]  Rev Med Interne  2010;31;4  
•  Piguet AC, Stroka D, Zimmermann A, Dufour JF. Hypoxia aggravates non-alcoholic steatohepatitis in mice lacking hepatocellular PTEN.  Clinical science (London, England : 1979)  2010;118;6  
•  Dufour JF, Johnson P. Liver cancer: from molecular pathogenesis to new therapies: summary of the EASL single topic conference.  J. Hepatol.  2010;52;2  
•  Sgier C, Müllhaupt B, Gerlach T, Moradpour D, Negro F, Malé PJ, Heim MH, Malinverni R, Cerny A, Dufour JF. Effect of antiviral therapy on circulating cytokeratin-18 fragments in patients with chronic hepatitis C.  J. Viral Hepat.  2010  
•  Chtioui H, Mauerhofer O, Günther B, Dufour JF. Macro-AST in an asymptomatic young patient.  Ann Hepatol  2010;9;1  
•  Dufour JF. Treat the bones and get less rejection!  Liver Int.  2009  
•  Dufour JF. The evasive promise of antiangiogenic therapy.  J. Hepatol.  2009;51;5  
•  Bochud PY, Cai T, Overbeck K, Bochud M, Dufour JF, Müllhaupt B, Borovicka J, Heim M, Moradpour D, Cerny A, Malinverni R, Francioli P, Negro F. Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C.  J. Hepatol.  2009;51;4  
•  Balmer ML, Siegrist K, Zimmermann A, Dufour JF. Effects of ursodeoxycholic acid in combination with vitamin E on adipokines and apoptosis in patients with nonalcoholic steatohepatitis.  Liver Int.  2009;29;8  

[ See timeline ] [ See all publications ]